INTERIM REPORT
JANUARY 1 – JUNE 30, 2025

Continued improvement in margins and profit

The companies within AddLife continue to develop in line with our priorities. Margins are strengthening in both business areas thanks to continuous development of product portfolios and good cost control. Growth was strong in Labtech, and in Medtech, demand was steadily increasing, but was held back somewhat, mainly due to the timing of capital investments in certain countries. Our acquired companies are contributing further to the positive development of margins and growth. Profit for the period improved by 39 percent in the quarter.

Fredrik Dalborg, President and CEO

SECOND QUARTER

  • Net sales increased by 1 percent to SEK 2,578m (2,554). The organic growth, excluding exchange rate changes, was 3 percent and the acquired growth was 2 percent.
  • EBITA excl. one-off costs increased by 5 percent to SEK 307m (292), corresponding to an EBITA margin of 11,9 percent (11.4).
  • Profit after tax increased by 39 percent to SEK 100m (72).
  • Earnings per share amounted to SEK 0.83 (0.60).
  • Cash flow from operating activities amounted to SEK 119m (195).
  • In April, the acquisition of Edge Medical Ltd., United Kingdom, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 90m.

 

JANUARY –  JUNE, 2025

  • Net sales increased by 3 percent to SEK 5,280m (5,124). The organic growth, excluding exchange rate changes, was 4 percent and the acquired growth was 1 percent.
  • EBITA increased by 10 percent to SEK 650m (590), corresponding to an EBITA margin of 12.3 percent (11.5).
  • Profit after tax increased by 63 percent to SEK 220m (135).
  • Earnings per share amounted to SEK 1.81 (1.11). Earnings per share for the last 12 months amounted to SEK 2.76 (0.97).
  • Cash flow from operating activities amounted to SEK 359m (292).
  • The equity ratio was 41 percent (41).
  • Return on working capital (P/WC) amounted to 53 percent (51).
  Q2 Q2 ∆ Jan-Jun Jan-Jun ∆ Jul 2024- Full year
SEKm 2025 2024 % 2025 2024 % Jun 2025 2024
Net sales 2,578 2,554 1 5,280 5,124 3 10,442 10,286
EBITA 307 299 3 650 590 10 1,219 1,159
EBITA margin, % 11.9 11.7   12.3 11.5   11.7 11.3
Adjusted EBITA 307 292 5 650 589 10 1,226 1,165
Adjusted EBITA margin, % 11.9 11.4   11.9 11.5   11.7 11.3
Profit/loss before taxes 146 113 29 318 213 49 510 405
Profit for the period 100 72 39 220 135 63 339 254
Earnings per share (EPS), before/after dilution, SEK 0.83 0.60 38 1.81 1.11 63 2.76 2.06
Cash flow from operating activities 119 195 -39 359 292 23 1,162 1,095
Dynamisk graf: Net sales (SEKm)
Dynamisk graf: EBITA (SEKm)

 

Latest updated: 7/14/2025 3:57:56 PM by jamilah.wass@add.life
NEXT